SURGERY FOR OBESITY

Authors
Citation
Fl. Greenway, SURGERY FOR OBESITY, Endocrinology and metabolism clinics of North America, 25(4), 1996, pp. 1005
Citations number
190
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
08898529
Volume
25
Issue
4
Year of publication
1996
Database
ISI
SICI code
0889-8529(1996)25:4<1005:SFO>2.0.ZU;2-#
Abstract
The medical risks of obesity increase exponentially as weight increase s, and these risks are reduced by sustained weight loss. Behavior modi fication and dieting provide an approximately 6% loss of body weight a t 1 year. Fenfluramine provides an approximately 8% weight loss at 1 y ear, which can be doubled to 16% when a drug such as phentermine, whic h works through a different biochemical mechanism, is added to it. Thi s amount of weight loss is insufficient for many severely obese indivi duals. It was with these facts in mind that the National Institutes of Health Consensus Conference in 1992 recommended that obesity surgery is an appropriate treatment for patients with a body mass index greate r than 40 kg/m(2) who had failed in attempts at medical treatment and for patients with a body mass index greater than 35 kg/m(2) with sever e complications of obesity. Vertically banded gastroplasty and Roux-en -Y gastric bypass are the two operations presently recommended because of their relative safety and effectiveness. This article reviews prev ious procedures that have provided insight into the mechanisms by whic h these surgeries cause weight loss. The presently used surgeries and their results also are reviewed because until medical therapy improves substantially, surgery remains the most reasonable treatment option f or most morbidly obese patients.